Physician profile
Melissa E Prihoda
NPI 1003059932
$1,509.54
in general payments reported to CMS, 2019-2025
23 companies · $413 in 2025
The $413 reported for 2025 was more than what 91% of Pediatrics providers received nationally (typical 2025 total: $96.93).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $442 · 2020: $42.83 · 2022: $28.75 · 2023: $195 · 2024: $388 · 2025: $413.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $996.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $995.74 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Ironshore Pharmaceuticals INC. | $181.87 | 2019-2024 | Jornay Pm |
| Pfizer INC. | $175.90 | 2019-2023 | |
| Sanofi-Aventis U.S. LLC | $142.69 | 2024-2025 | |
| Corium, LLC | $136.64 | 2023-2025 | Azstarys |
| Supernus Pharmaceuticals, INC. | $105.97 | 2023-2025 | Qelbree, Qelbree |
| Neos Therapeutics, LP | $103.91 | 2019-2025 | Cotempla Xr-Odt, Adzenys Xr-Odt |
| Cranial Technologies, INC | $103.05 | 2019-2025 | Doc Band |
| Collegium Pharmaceutical, INC. | $78.83 | 2025 | Jornay Pm |
| Sanofi Pasteur INC. | $68.99 | 2023-2025 | |
| Sobi, INC | $67.26 | 2019 | |
| Alk-Abello, INC | $53.49 | 2023-2025 | Neffy, Odactra, Grastek |
| Genentech USA, INC. | $50.12 | 2019-2020 | |
| Merck Sharp & Dohme LLC | $33.77 | 2022-2024 | Vaxneuvance, Gardasil, Gardasil 9 |
| Shire North American Group INC | $27.35 | 2019 | |
| Ultragenyx Pharmaceutical INC. | $27.19 | 2024 | Crysvita |
Show all 23 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Acadia Pharmaceuticals INC | $26.26 | 2024 | Daybue |
| Ars Pharmaceuticals Operations, INC. | $24.33 | 2025 | Neffy |
| Ironwood Pharmaceuticals, INC | $22.49 | 2024 | |
| Verrica Pharmaceuticals INC. | $20.90 | 2024 | Ycanth |
| Seqirus USA INC | $18.77 | 2025 | Flucelvax |
| Phadia US INC. | $14.42 | 2024 | Immunocap |
| Agile Therapeutics, INC. | $12.88 | 2022 | |
| Adlon Therapeutics L.P. | $12.46 | 2019 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Melissa Prihoda listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.